SG/CALL/SIEMENS HEALTHINEERS/75/0.1/21.03.25 Share Price

Warrant

DE000SU92FE3

Market Closed - Bid/Ask 08:20:56 10/05/2024 BST After market 19:02:55
0.047 EUR +4.44% Intraday chart for SG/CALL/SIEMENS HEALTHINEERS/75/0.1/21.03.25 0.053 +12.77%
Current month-28.57%
1 month-45.78%
Date Price Change Volume
10/05/24 0.047 +4.44% 0
09/05/24 0.045 -10.00% 0
08/05/24 0.05 +16.28% 0
07/05/24 0.043 -23.21% 0
06/05/24 0.056 +3.70% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 08:20 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SIEMENS HEALTHINEERS AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU92FE
ISINDE000SU92FE3
Date issued 29/02/2024
Strike 75
Maturity 21/03/2025 (315 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.13
Lowest since issue 0.043

Company Profile

Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Sector
-
More about the company

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Siemens Healthineers AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.48 EUR
Average target price
60.57 EUR
Spread / Average Target
+15.41%
Consensus